LexDanaLexDanabeta
Inventor

ANDREAS REIK

Inventor
US

Overview

4→
Patents
2022–2026
Patent span
Chemistry
Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides31%
C12NMicroorganisms or enzymes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
12,516,098Chimeric antigen receptor mediated cell targeting202611,884,930Method of inactivating a glucocorticoid receptor gene in an isolated cell202411,492,643Methods and compositions for treatment of a genetic condition202211,235,026Methods and compositions for modulating PD12022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to SANGAMO THERAPEUTICS INC (4)· patent assignee history
2022–2026Based in US· patent location history
2024Patents assigned to HOPE CITY (1)· patent assignee history
2024Patents assigned to SANGAMO BIOSCIENCES INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANGAMO THERAPEUTICS INC42022–2026
HOPE CITY12024
SANGAMO BIOSCIENCES INC12024
Locations
LocationPatentsSpan
US42022–2026